I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 9 studies | 20% ± 7% | |
| endothelial cell | 8 studies | 21% ± 5% | |
| natural killer cell | 7 studies | 19% ± 3% | |
| CD4-positive, alpha-beta T cell | 5 studies | 21% ± 4% | |
| epithelial cell | 5 studies | 37% ± 21% | |
| naive B cell | 4 studies | 18% ± 2% | |
| B cell | 4 studies | 20% ± 3% | |
| basal cell | 4 studies | 21% ± 6% | |
| glutamatergic neuron | 4 studies | 28% ± 9% | |
| naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 21% ± 2% | |
| effector memory CD8-positive, alpha-beta T cell | 3 studies | 22% ± 4% | |
| hematopoietic precursor cell | 3 studies | 22% ± 9% | |
| mature NK T cell | 3 studies | 18% ± 0% | |
| pericyte | 3 studies | 18% ± 1% | |
| abnormal cell | 3 studies | 21% ± 5% | |
| gamma-delta T cell | 3 studies | 29% ± 14% | |
| regulatory T cell | 3 studies | 18% ± 2% | |
| GABAergic neuron | 3 studies | 25% ± 4% | |
| CD8-positive, alpha-beta T cell | 3 studies | 20% ± 3% | |
| dendritic cell | 3 studies | 32% ± 9% | |
| connective tissue cell | 3 studies | 19% ± 3% | |
| neuron | 3 studies | 24% ± 7% | |
| oligodendrocyte | 3 studies | 16% ± 1% | |
| erythroblast | 3 studies | 25% ± 6% |
